Prevalence of rifampicin-resistant pediatric tuberculosis by cartridge-based nucleic acid amplification test at the intermediate reference laboratory under revised national tuberculosis control program India: A multidimensional approach
نویسندگان
چکیده
منابع مشابه
Notification of tuberculosis cases in India: Moving ahead in Revised National Tuberculosis Control Program
Tuberculosis (TB) is currently the leading cause of death from a curable infectious disease accounting for 8.7 million new cases and 1.4 million deaths in the year 2011. From the year 2012, TB is a notifiable disease in India which means that all cases of TB diagnosed by any means has to be reported to the public health authorities. This would help policy makers to make rational decisions with ...
متن کاملBlood levels of pyrazinamide in children at doses administered under the Revised National Tuberculosis Control Program.
OBJECTIVES To evaluate the blood levels, pharma-cokinetics and pharmacodynamic indices of pyrazinamide (PZA) in children suffering from tuberculosis, at doses administered under the weight band system of Revised National Tuberculosis Control Program of India (RNTCP) of India. DESIGN Prospective, open-label, non-randomized single-dose study. SETTING 20 children in the age group 5-12 years at...
متن کاملBridging Gaps in Revised National Tuberculosis Control Program at Bankura District, West Bengal State, India
Background: Tuberculosis distresses economically productive age groups and emerged as a noteworthy reason of global burden. Objectives: The study was undertaken to find the gaps at the level of patients, or health providers in implementing RNTCP and also find out the reasons therein. Methods: This study was carried out among all patients enrolled as pulmonary tuberculosis cases in DOTs register...
متن کاملMultidrug Resistant Tuberculosis; a Pharmacological view based on Revised National Tuberculosis Control Programme DOTS-Plus Guidelines
–Directly Observed Therapy Strategy (DOTS) -Plus is a part of DOTS program that adds approach for multidrug resistance tuberculosis (MDR-TB) diagnosis, management, and treatment. WHO approved DOTS-Plus program began in 2000 and was established to encourage access to high quality second line drugs for appropriate use in MDR-TB control programs. The top priority is to prevent the emergence of MDR...
متن کاملRevised National Tuberculosis Control Program in India: The Need to Strengthen
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It is spread through the air from people suffering from TB. A single patient can infect ten or more people in one year. TB remains a major public health problem in India, with the country accounting for 26% of all TB cases reported globally. In 2011, out of the estimated global annual incidence of 8.8...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biomedical and Biotechnology Research Journal (BBRJ)
سال: 2018
ISSN: 2588-9834
DOI: 10.4103/bbrj.bbrj_114_18